Cargando…
The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months’ follow-up
BACKGROUND: Recently risedronate is suggested to be effective for the prevention and treatment of for osteoporosis in total hip arthroplasty. This meta-analysis aimes to evaluate the efficacy of risedronate in reducing femoral periprosthetic bone mineral density loss in patients undergoing primary t...
Autor principal: | Yang, Liqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904972/ https://www.ncbi.nlm.nih.gov/pubmed/29665839 http://dx.doi.org/10.1186/s13018-018-0808-z |
Ejemplares similares
-
Comment on “The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months’ follow-up”
por: Kai Huang, M. M., et al.
Publicado: (2022) -
Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate
por: Kamimura, Mikio, et al.
Publicado: (2016) -
Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis
por: Li, Qifeng, et al.
Publicado: (2018) -
Efficacy of risedronate in improving bone mineral density in patients undergoing total hip arthroplasty: A meta-analysis of randomized controlled trials
por: Su, Jing, et al.
Publicado: (2018) -
Letter to the Editor: Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis
por: Huang, Kai, et al.
Publicado: (2022)